Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

A timeline of tumour-associated macrophage biology
Luca Cassetta, Jeffrey W. Pollard
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 238-257
Closed Access | Times Cited: 259
Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
Fangmin Chen, Tianliang Li, Huijuan Zhang, et al.
Advanced Materials (2022) Vol. 35, Iss. 10
Closed Access | Times Cited: 68
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 65
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 57
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 17
The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Xue Chen, Yunxiao Zhang, Yao Fu
Medicine in Drug Discovery (2022) Vol. 14, pp. 100122-100122
Open Access | Times Cited: 54
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Iva Truxová, David Cibula, Radek Špíšek, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005968-e005968
Open Access | Times Cited: 36
Tumor‐targeted nano‐adjuvants to synergize photomediated immunotherapy enhanced antitumor immunity
Hongda Zhu, Chaobo Yang, Aqin Yan, et al.
View (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 36
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 12
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
M.M. Leblond, Hana Zdimerova, Emma Desponds, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4712-4712
Open Access | Times Cited: 48
Tumor-targeted self-assembled micelles reducing PD-L1 expression combined with ICIs to enhance chemo-immunotherapy of TNBC
Hongda Zhu, Kai Ma, Rui Ruan, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108536-108536
Closed Access | Times Cited: 17
Lactic acid in macrophage polarization: A factor in carcinogenesis and a promising target for cancer therapy
Mobarakeh Ajam-Hosseini, Romina Heydari, Milad Rasouli, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116098-116098
Closed Access | Times Cited: 6
Integrative multi-omics analysis reveals the role of toll-like receptor signaling in pancreatic cancer
Jie Peng, Jiaao Sun, Youfeng Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Innovative Strategies in Oncology: Bacterial Membrane Vesicle-Based Drug Delivery Systems for Cancer Diagnosis and Therapy
Guodong Li, Shiyun Pu, Lingchong You, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 58-58
Open Access
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung Carcinoma
Silvia Ceccarelli, Viola Pasqua Marzolesi, Jacopo Vannucci, et al.
Lung (2025) Vol. 203, Iss. 1
Open Access
Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy
Veronique Beiss, Chenkai Mao, Steven Fiering, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 5, pp. 1573-1585
Open Access | Times Cited: 25
Constructing a nanocage-based universal carrier for delivering TLR-activating nucleic acids to enhance antitumor immunotherapy
Baoli Zhang, Xuehui Chen, Guoheng Tang, et al.
Nano Today (2022) Vol. 46, pp. 101564-101564
Closed Access | Times Cited: 23
Targeting the innate immune system with nanoparticles for cancer immunotherapy
Kai Li, Zhicheng Zhang, Yu Mei, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 11, pp. 1709-1733
Closed Access | Times Cited: 22
Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy
Yi Wang, Sheng‐Lin Qiao, Jie Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 22
Closed Access | Times Cited: 14
New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment
Ji‐Yong Sung, Jae‐Ho Cheong
Cells (2022) Vol. 11, Iss. 5, pp. 768-768
Open Access | Times Cited: 21
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
Bettina Hoden, David DeRubeis, Margarita Martinez-Moczygemba, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004799-e004799
Open Access | Times Cited: 20
Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
Sabina Sánchez Hernández, Martin R. Jakobsen, Rasmus O. Bak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11397-11397
Open Access | Times Cited: 19
Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, et al.
Bioimpacts (2022)
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top